"ASX-listed diagnostic imaging business Cyclopharm is seeking a capital injection to fund its rollout in the United States.
The company had Bell Potter at hand in its quest to raise $30 million, via a placement of new shares.
The shares were being offered to funds at $2.60 each, according to a term sheet in front of potential investors. The company's shares last traded at $2.94."
snip from the AFR
"ASX-listed diagnostic imaging business Cyclopharm is seeking a...
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
0.000(0.00%) |
Mkt cap ! $169.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.80 | 287 | 1 |
View Market Depth
| Last trade - 16.12pm 03/05/2024 (20 minute delay) ? |
| CYC (ASX) Chart |
Day chart unavailable